Global Menopause Market

Global Menopause Market Size, Share, Growth Analysis, By Applications(Screening and Diagnosis), By End User(Hospital, Diagnostic Centres) - Industry Forecast 2023-2030


Report ID: SQMIG35I2115 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 62 | Figures: 78

Global Menopause Market Insights

Global Menopause Market was valued at USD 16.9 Billion in 2022 and is poised to grow from USD 17.8 Billion in 2023 to USD 26.97 Billion by 2031, at a CAGR of 5.33% during the forecast period (2024-2031). 

Menopause is a natural biological process that marks the end of a woman's reproductive years. It usually occurs between the ages of 45 and 55, and is characterized by the cessation of menstrual periods. During menopause, women may experience a range of symptoms, including hot flashes, night sweats, mood changes, and vaginal dryness. There is a growing market for nutritional supplements and other products that are designed to help women manage the symptoms of menopause. These products include herbal supplements, vitamins, minerals, and other dietary supplements, as well as over-the-counter and prescription medications. The global menopause market is expected to grow significantly in the coming years, driven by factors such as increasing awareness about the health benefits of nutritional supplements, growing demand for natural and organic products, and rising incidence of menopause-related health issues. Also, the menopause market is driven by a number of factors, including the aging of the global population, rising awareness of menopause-related health issues, and growing demand for natural and organic products. In addition, women are becoming more active and engaged in managing their health and wellness during menopause, which is driving the development of new products and services. 

The increasing prevalence of vasomotor and menopausal symptoms, such as night sweats and hot flashes, among women during the menopausal transition is anticipated to drive market growth. Menopausal symptoms, including mood swings, difficulty concentrating, and depression, are also associated with this phase. A study published in the International Journal of Applied & Basic Medical Research revealed that 36.7% of women reported hot flashes among the 87.7% experiencing menopausal symptoms. Anxiety was the most reported symptom at 80%, followed by sleep issues at 61.2%. While hormone replacement therapy remains the primary treatment for menopausal symptoms, particularly vasomotor symptoms, its use is associated with potential adverse effects such as vaginal bleeding, fractures, dementia, urinary incontinence, breast cancer, heart attack, blood clots, stroke, and colorectal cancer. Consequently, patients are increasingly seeking safer alternatives like plant-based products and dietary supplements. The pandemic negatively impacted the mental health of women, leading to hormonal imbalances and an exacerbation of vasomotor symptoms. Despite the initial adverse effects on the market, sales of over-the-counter pharmaceutical products and dietary supplements witnessed a surge in the third and fourth quarters of 2020. A study by the Council for Responsible Nutrition (CRN) in August 2020 reported an increase in dietary supplement usage during the pandemic. The growing demand for dietary supplements is expected to persist due to a shift in consumer preference toward nature-based alternatives over synthetic pharmaceutical products.

US Menopause Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 16.9 Billion

Largest Segment

Dietary Supplements

Fastest Growth

Dietary Supplements

Growth Rate

5.33% CAGR

Global Menopause Market Market 2022-2030 ($ Bn)
Country Share for North America Region- 2022 (%)
Global Menopause Market Market Size By End User 2022-2030 ($ Bn)
Global Menopause Market Market Size By End User 2022-2030 ($ Bn)

To get more reports on the above market click here to Buy The Report

Global Menopause Market Segmental Analysis

Global Menopause Market is segmented based on treatment, and region. Based on treatment, the market is segmented into dietary supplements, OTC pharma products. Further, OTC pharma products is segmented into hormonal and non-hormonal. Based on region, the global Menopause Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Menopause Market Analysis by Treatment

During the projected period, the dietary supplements segment dominated the market for Menopause in 2022. This dominance is attributed to factors such as, advantages of nutritional supplements and dangers of hormone replacement therapy. According to a study that was written up in the Journal for Nutraceuticals, supplements like primrose oil, black cohosh, soy isoflavones, and chasteberry helped to relieve hot flashes with sweating, depression, and sleep problems.

The OTC pharmaceutical products market is anticipated to grow profitably during the forecast period. This can be attributed to a change in pharmaceutical companies' development of over-the-counter (OTC) medications to treat menopausal symptoms. For instance, Theramex purchased the product license for Femarelle, an over-the-counter medication used to treat menopausal symptoms, in November 2021. By 2022, the product—which was initially developed by Se-cure Pharmaceuticals Ltd.—will be accessible in a number of nations.

Global Menopause Market Market By Treatment, 2022 (%), 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Global Menopause Market Regional Insights

The North America region is anticipated to dominate the market for Menopause market. This dominance is owing to the large population of women undergoing menopause in North America, which increases demand for menopause-related goods and services. Also, compared to other markets, the North American market may have healthcare systems that are more advanced and greater access to these goods and services.

However, due to the rising demand for menopause-related goods and services as well as the increased knowledge of symptoms associated to the menopause, emerging regions like Asia-Pacific and Latin America may present considerable growth potential. Moreover, factors including rising disposable incomes, bettering healthcare infrastructure, and expanding healthcare spending may support the expansion of the menopausal market in these areas.

Global Menopause Market Market By Geography, 2022-2030, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Menopause Market Dynamics

Menopause Market Drivers

  • There are several factors driving the menopause market such as, aging population, rising awareness, lifestyle factors, and technological advancements. Also, Changing attitudes and Healthcare access and affordability are some of the other factors driving the market. As the global population ages, more women will enter menopause, leading to a larger market for menopause-related products and services. This demographic trend is expected to continue for the foreseeable future, as life expectancies increase and birth rates decline in many regions. For instance, The North American Menopause Association estimates that 2 million women in the United States experience menopause every year, or roughly 6,000 women every day. According to UN statistics, there will be 985 million women in 2020 who are 50 years of age or older. By 2050, this figure is anticipated to reach 1.65 billion. The market for menopause products has been significantly boosted by growing public knowledge of menopause and its symptoms. The changes that take place during menopause and the health hazards linked to it are becoming well known to women. The demand for goods and services that can assist manage menopause symptoms, like hormone therapy, herbal supplements, and lifestyle changes, has surged as a result of this raised awareness. Lifestyle factors, such as poor diet and lack of exercise, can exacerbate menopause symptoms and increase the demand for products and services that address these issues. Women are increasingly recognizing the importance of a healthy lifestyle during menopause, which has led to a growing market for products and services that promote wellness during this phase of life.
  • The factors such as development of non-hormonal therapies, personalized medicine, and digital health solutions along with shifting trend towards natural and herbal remedies is anticipated to offer several opportunities for the market. Although hormone replacement therapy (HRT) has long been the main treatment for menopause symptoms, non-hormonal alternatives are becoming more and more popular. Pharmaceutical firms and healthcare professionals have a chance to develop efficient non-hormonal treatments for symptoms like hot flashes, vaginal dryness, and mood swings. Also, there is no one-size-fits-all approach to treatment for menopause because it affects women differently. The menopausal market may offer a sizable opportunity for personalized treatment that takes into account a woman's particular symptoms, medical history, and lifestyle. Moreover, telemedicine, wearable technology, and other digital health solutions could help women going through menopause. There is a chance to create digital health products that support women in tracking their symptoms, getting support and guidance, and communicating with medical professionals.
  • Furthermore, Education and Support are crucial to the market's expansion. Education and assistance for women going through menopause are desperately needed. Businesses that provide advocacy programs, support networks, and instructional resources could be very helpful in meeting this demand.

Menopause Market Restraints

  • Even though the market has significant potential to grow, the factors such as safety concerns, lack of awareness and stigma, regulatory hurdles, and limited research and development may hinder the market growth. Breast cancer, heart disease, and stroke risk have all been found to be higher in women who use hormone replacement therapy (HRT). As a result, there are now worries regarding the safety of HRT and a rising need for non-hormonal treatments. It may be difficult for businesses that specialize in hormone-based therapy to solve these safety issues. Menopause is still a taboo subject in many countries, and little is known and understood about it and how it affects women's health. This may reduce demand and make it challenging for businesses to properly promote menopause goods and services. Also, the menopausal market is governed by stringent regulatory standards, especially for hormone-based treatments. Prior to being licensed for use, new medications and therapies developed by companies must pass strict safety and efficacy requirements. However, there is still a lot to learn about menopause and how it affects women's health. The availability of efficient treatments and therapies could be hampered by the lack of research and development in the field. These are a few of the elements that can impede the market's expansion.

Request Free Customization of this report to help us to meet your business objectives.

Global Menopause Market Competitive Landscape

With a wide range of businesses joining the market and creating new products and services to meet the demands of women going through menopause, the menopause market is getting more and more competitive. As the industry expands, competition is likely to heat up, forcing businesses to stand out via innovation, efficacy, and safety in order to gain market share.

Menopause Market Top Player’s Company Profiles

  • Pfizer Inc.
  • Novo Nordisk A/S
  • Allergan plc
  • TherapeuticsMD Inc.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Merck & Co. Inc.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Amgen Inc.
  • AbbVie Inc.
  • Pfizer Inc.
  • Novartis International AG
  • Procter & Gamble Co.
  • Roche Holding AG
  • Sanofi SA
  • Serenity Pharmaceuticals LLC
  • Mithra Pharmaceuticals SA

Menopause Market Recent Developments

  • In May 2023, Astellas Pharma Inc. obtained approval from the FDA for VEOZAH, a groundbreaking nonhormonal neurokinin 3 (NK3) receptor antagonist. This marks the first-of-its-kind approval for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. 
  • In March 2023, Amyris, Inc. acquired MenoLabs, LLC, a company specializing in menopause treatment and research in this field. This strategic acquisition is poised to facilitate the expansion of Amyris, Inc.'s product portfolio in the realm of menopause treatments. 
  • In March 2022, Aptorum Group Limited, announced the highly anticipated commercial introduction of NativusWell®. This new dietary supplement is designed to support women's health during the various stages of menopause and is specifically targeted for the Chinese market. 

Global Menopause Key Market Trends

  • Owing to concerns about the potential hazards of hormone-based treatments, many women are searching for non-hormonal therapy to treat the symptoms of menopause. As a result, there is an increasing need for non-hormonal treatments such herbal medicines, CBT, and mindfulness-based treatments.
  • For managing menopause symptoms, telemedicine, online support groups, and smartphone apps are becoming more and more common. These options provide comfort, accessibility, and privacy, which may be especially alluring to women who are reluctant to seek menopause-related medical care.
  • Healthcare professionals are becoming more aware of the significance of menopause and how it affects women's health. As a result, there is now increased emphasis on menopause in healthcare, and both women and healthcare professionals have access to more resources and knowledge.
  • For the purpose of creating novel remedies for menopause symptoms, businesses are investing in research and development. This covers both hormonal and non-hormonal treatments, as well as technological advances in healthcare.

Global Menopause Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our global menopause market analysis, due to growing aging population, rising awareness, lifestyle factors, and technological advancements are driving the market growth. As the market continues to grow, companies will need to focus on innovation and partnerships to remain competitive.

Report Metric Details
Market size value in 2023 USD 16.9 Billion
Market size value in 2031 USD 26.97 Billion
Growth Rate 5.33%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Applications
    • Screening and Diagnosis
  • End User
    • Hospital, Diagnostic Centres, Specialty Clinics, Others.
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Pfizer Inc.
  • Novo Nordisk A/S
  • Allergan plc
  • TherapeuticsMD Inc.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Merck & Co. Inc.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Amgen Inc.
  • AbbVie Inc.
  • Pfizer Inc.
  • Novartis International AG
  • Procter & Gamble Co.
  • Roche Holding AG
  • Sanofi SA
  • Serenity Pharmaceuticals LLC
  • Mithra Pharmaceuticals SA

Menopause Market Recent Developments

  • In May 2023, Astellas Pharma Inc. obtained approval from the FDA for VEOZAH, a groundbreaking nonhormonal neurokinin 3 (NK3) receptor antagonist. This marks the first-of-its-kind approval for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. 
  • In March 2023, Amyris, Inc. acquired MenoLabs, LLC, a company specializing in menopause treatment and research in this field. This strategic acquisition is poised to facilitate the expansion of Amyris, Inc.'s product portfolio in the realm of menopause treatments. 
  • In March 2022, Aptorum Group Limited, announced the highly anticipated commercial introduction of NativusWell®. This new dietary supplement is designed to support women's health during the various stages of menopause and is specifically targeted for the Chinese market. 
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Menopause Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Menopause Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Menopause Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Menopause Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Menopause Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Menopause Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Menopause Market was valued at USD 16.9 Billion in 2022 and is poised to grow from USD 17.8 Billion in 2023 to USD 26.97 Billion by 2031, at a CAGR of 5.33% during the forecast period (2024-2031). 

With a wide range of businesses joining the market and creating new products and services to meet the demands of women going through menopause, the menopause market is getting more and more competitive. As the industry expands, competition is likely to heat up, forcing businesses to stand out via innovation, efficacy, and safety in order to gain market share. 'Pfizer Inc.', 'Novo Nordisk A/S', 'Allergan plc', 'TherapeuticsMD Inc.', 'Mylan N.V.', 'Teva Pharmaceutical Industries Ltd.', 'Bayer AG', 'Merck & Co. Inc.', 'Johnson & Johnson', 'GlaxoSmithKline plc', 'Eli Lilly and Company', 'Amgen Inc.', 'AbbVie Inc.', 'Pfizer Inc.', 'Novartis International AG', 'Procter & Gamble Co.', 'Roche Holding AG', 'Sanofi SA', 'Serenity Pharmaceuticals LLC', 'Mithra Pharmaceuticals SA', 'In May 2023, Astellas Pharma Inc. obtained approval from the FDA for VEOZAH, a groundbreaking nonhormonal neurokinin 3 (NK3) receptor antagonist. This marks the first-of-its-kind approval for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. ', 'In March 2023, Amyris, Inc. acquired MenoLabs, LLC, a company specializing in menopause treatment and research in this field. This strategic acquisition is poised to facilitate the expansion of Amyris, Inc.'s product portfolio in the realm of menopause treatments. ', 'In March 2022, Aptorum Group Limited, announced the highly anticipated commercial introduction of NativusWell®. This new dietary supplement is designed to support women's health during the various stages of menopause and is specifically targeted for the Chinese market. '

There are several factors driving the menopause market such as, aging population, rising awareness, lifestyle factors, and technological advancements. Also, Changing attitudes and Healthcare access and affordability are some of the other factors driving the market. As the global population ages, more women will enter menopause, leading to a larger market for menopause-related products and services. This demographic trend is expected to continue for the foreseeable future, as life expectancies increase and birth rates decline in many regions. For instance, The North American Menopause Association estimates that 2 million women in the United States experience menopause every year, or roughly 6,000 women every day. According to UN statistics, there will be 985 million women in 2020 who are 50 years of age or older. By 2050, this figure is anticipated to reach 1.65 billion. The market for menopause products has been significantly boosted by growing public knowledge of menopause and its symptoms. The changes that take place during menopause and the health hazards linked to it are becoming well known to women. The demand for goods and services that can assist manage menopause symptoms, like hormone therapy, herbal supplements, and lifestyle changes, has surged as a result of this raised awareness. Lifestyle factors, such as poor diet and lack of exercise, can exacerbate menopause symptoms and increase the demand for products and services that address these issues. Women are increasingly recognizing the importance of a healthy lifestyle during menopause, which has led to a growing market for products and services that promote wellness during this phase of life.

Owing to concerns about the potential hazards of hormone-based treatments, many women are searching for non-hormonal therapy to treat the symptoms of menopause. As a result, there is an increasing need for non-hormonal treatments such herbal medicines, CBT, and mindfulness-based treatments.

The North America region is anticipated to dominate the market for Menopause market. This dominance is owing to the large population of women undergoing menopause in North America, which increases demand for menopause-related goods and services. Also, compared to other markets, the North American market may have healthcare systems that are more advanced and greater access to these goods and services.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Menopause Market

Product ID: SQMIG35I2115

$5,300
BUY NOW GET FREE SAMPLE